Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2020
Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes
10 March 2020 - The terminology used to describe community participation in health technology assessment is contested and frequently confusing. ...
Posted by Michael Wonder on 25 Feb 2020
TLV has decided on a policy for patient participation
21 February 2020 - TLV has taken another step in developing patient participation by developing a policy. ...
Posted by Michael Wonder on 29 Jan 2020
The FDA wants to know how Instagram influencers sway patient views on medicines
28 January 2020 - In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social media, ...
Posted by Michael Wonder on 17 Jan 2020
Use of patient preference studies in HTA decision making: a NICE perspective
16 January 2020 - Patient preference studies could provide valuable insights to a National Institute for Health and Care Excellence committee ...
Posted by Michael Wonder on 02 Dec 2019
Engaging patients in medicines regulation: a tale of two agencies
2 December 2019 - The EMA and the US FDA have committed to engaging patients in their regulatory processes to promote ...
Posted by Michael Wonder on 10 Nov 2019
Patient perspective is vital to FDA's work
7 November 2019 - As an oncologist, I was eager to come work at the U.S. FDA, where I knew ...
Posted by Michael Wonder on 02 Oct 2019
Advancing patient engagement
2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...
Posted by Michael Wonder on 23 Sep 2019
Statement on FDA efforts to encourage patient engagement in medical device clinical investigations
23 September 2019 - At the U.S. FDA we are committed to keeping patients, their families and caregivers at the center ...
Posted by Michael Wonder on 06 Aug 2019
A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number.
2 August 2019 - Health economists walk a precarious tightrope: their analyses are quantitative and, presumably, emotion-free. But health care ...
Posted by Michael Wonder on 31 Jul 2019
Patient preferences studies: how NICE aims to make use of them
2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...
Posted by Michael Wonder on 27 Jul 2019
Stories of patient involvement impact in health technology assessments: a discussion paper
24 July 2019 - As more health technology assessment bodies seek to implement patient involvement, there is a desire to learn ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...
Posted by Michael Wonder on 01 Jul 2019
Ethical challenges related to patient involvement in health technology assessment
28 June 2019 - Including information and values from patients in HTA has the potential to improve both the process and ...
Posted by Michael Wonder on 24 Jun 2019
Incorporating patient preferences in non-inferiority trials
24 June 2019 - Non-inferiority trials imply a trade-off between a loss in efficacy of a standard treatment in exchange for ...
Posted by Michael Wonder on 15 Jun 2019
Asthma and Allergy Foundation of America elevates patient voice in ICER review of new peanut allergy treatments
14 June 2019 - On June 11 in Oakland, CA the Institute for Clinical and Economic Review and its California Technology ...